Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Sankar Mitra
Introduction
Sankar Mitra is a notable inventor based in Houston, Texas. He has made significant contributions to the field of mitochondrial dysfunction treatments through his innovative research and patented technologies. His work focuses on developing novel therapies that address oxidative and metal-related toxicities.
Latest Patents
Sankar Mitra holds a patent for "Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphenic materials for use thereof." This patent includes modified hydrophilic carbon clusters (HCCs), poly(ethylene glycol)-hydrophilic carbon clusters (PEG-HCCs), and similarly structured materials like graphene quantum dots (GQDs). These materials have been enhanced with an iron chelating moiety, such as deferoxamine. By utilizing common binding sites, these carbon nanostructures facilitate intracellular transport, particularly in mitochondria. They also reduce oxidative breakdown of the chelator moiety prior to treatment, addressing both the causes and consequences of metal-induced oxidative stress within the body. This innovative approach provides a new form of therapy for a range of oxidative and metal-related toxicities.
Career Highlights
Throughout his career, Sankar Mitra has worked with prestigious institutions, including William Marsh Rice University and the University of Texas System. His research has garnered attention for its potential to revolutionize treatments for mitochondrial dysfunction.
Collaborations
Sankar has collaborated with esteemed colleagues such as James Mitchell Tour and Lizanne Nilewski. Their combined expertise has contributed to the advancement of research in the field of mitochondrial therapies.
Conclusion
Sankar Mitra's innovative work and patented technologies represent a significant advancement in the treatment of mitochondrial dysfunction. His contributions continue to pave the way for new therapeutic approaches in addressing oxidative and metal-related toxicities.